Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, pharmacokinetics and pharmacodynamics of multiple rising oral doses of BI 1021958 in healthy volunteers and contro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BI 1021958

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy, Asthma | Phase 1 | Status: COMPLETED